G6PD Deficiency Management and Prevention
Epidemiology and Population Risk
- The condition is most common in people of Mediterranean, African, Middle Eastern, Indian, and Southeast Asian descent 1, 2
- In African populations, 10-15% of individuals carry the African variant (GdA-) 3
- The Ashkenazi Jewish population has a relatively higher prevalence for certain genetic conditions, though G6PD specifically varies by ethnic background 4
Trigger Avoidance and Safe Medications
- Certain medications, particularly antimalarials (primaquine), antibiotics (dapsone, sulfonamides), and other oxidant drugs, can trigger hemolysis 1, 2
- Artemisinin-based combination therapies for malaria treatment are safe to use 3
- Chloroquine/hydroxychloroquine in standard doses appear relatively safe 3
Medication Contraindications
- Primaquine (antimalarial) is strictly contraindicated and can cause severe, life-threatening hemolysis 3, 2
- Dapsone (antibiotic) is strictly contraindicated and can cause severe, life-threatening hemolysis 1, 3
- Rasburicase (for tumor lysis syndrome) is strictly contraindicated and can cause severe, life-threatening hemolysis 1, 2
- Methylene blue (methylthioninium chloride) is strictly contraindicated and can cause severe, life-threatening hemolysis 1, 3, 2
- Sulfonamide antibiotics are strictly contraindicated and can cause severe, life-threatening hemolysis 2
Patient Monitoring and Education
- Patients should always inform every healthcare provider about their G6PD deficiency before receiving any medication 1
- Patients should screen first-degree relatives (parents, siblings, children) for G6PD deficiency 1
- Pregnant women with G6PD deficiency can safely use chloroquine for malaria prevention 3
- Women who are carriers (heterozygous) may have variable enzyme levels and require quantitative testing to determine their risk 1
Testing and Diagnosis
- If you have Mediterranean, African, Indian, or Southeast Asian ancestry, screening is recommended before starting any oxidant drugs 1, 2
- For newborns with severe jaundice not responding to phototherapy, G6PD testing should be performed 1
- Avoid testing during or immediately after a hemolytic episode, as results may be falsely normal 1